Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ATP synthase F1 subunit epsilon pseudogene 1 (ATP5F1EP1) is a human pseudogene, a non-functional segment of DNA that resembles the protein-coding gene ATP5F1E, which encodes the epsilon subunit of the mitochondrial ATP synthase F1 complex. Unlike ATP5F1E, ATP5F1EP1 does not encode a functional protein and therefore has no known direct biological activity, disease association, or therapeutic relevance as a target. It is a non-expressed genetic remnant. Consequently, ATP5F1EP1 is not considered a molecular, therapeutic, or pharmacological target. For target-based research concerning the ATP synthase epsilon subunit, the functional gene/protein ATP5F1E should be referenced instead.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ATP synthase F1 subunit epsilon pseudogene 1 (ATP5F1EP1).